The PI3K/AKT Pathway Inhibitor ISC-4 Induces Apoptosis and Inhibits Growth of Leukemia in Preclinical Models of Acute Myeloid Leukemia

Acute myeloid leukemia is a heterogeneous disease with a 5-year survival rate of 28.3%, and current treatment options constrained by dose-limiting toxicities. One of the key signaling pathways known to be frequently activated and dysregulated in AML is PI3K/AKT. Its dysregulation is associated with...

Полное описание

Библиографические подробности

Главные авторы:	Charyguly Annageldiyev, Su-Fern Tan, Shreya Thakur, Pavan Kumar Dhanyamraju, Srinivasa R. Ramisetti, Preeti Bhadauria, Jacob Schick, Zheng Zeng, Varun Sharma, Wendy Dunton, Sinisa Dovat, Dhimant Desai, Hong Zheng, David J. Feith, Thomas P. Loughran, Shantu Amin, Arun K. Sharma, David Claxton, Arati Sharma
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Frontiers Media S.A. 2020-04-01
Серии:	Frontiers in Oncology
Предметы:	AML isoselenocyanate-4 Akt apoptosis AraC xenograft
Online-ссылка:	https://www.frontiersin.org/article/10.3389/fonc.2020.00393/full
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!